Copyright
©The Author(s) 2015.
World J Hepatol. Mar 27, 2015; 7(3): 628-632
Published online Mar 27, 2015. doi: 10.4254/wjh.v7.i3.628
Published online Mar 27, 2015. doi: 10.4254/wjh.v7.i3.628
Table 4 Barcelona clinic liver cancer B substaging response rates according to mRECIST n (%)
| CR | PR | PD | SD | |
| B1 | 12 (25) | 29 (60.4) | 3 (6.25) | 3 (6.25) |
| B2 | 6 (22.2) | 13 (48) | 1 (3.7) | 7 (26.1) |
| B3 | 1 (7.6) | 4 (30.7) | 1 (7.6) | 7 (53.8) |
| B4 | - | - | 1 (50) | 1 (50) |
- Citation: Scaffaro LA, Stella SF, Alvares-Da-Silva MR, Kruel CDP. Survival rates according to barcelona clinic liver cancer sub-staging system after transarterial embolization for intermediate hepatocellular carcinoma. World J Hepatol 2015; 7(3): 628-632
- URL: https://www.wjgnet.com/1948-5182/full/v7/i3/628.htm
- DOI: https://dx.doi.org/10.4254/wjh.v7.i3.628